RICHARD KELLERMAYER to Infliximab
This is a "connection" page, showing publications RICHARD KELLERMAYER has written about Infliximab.
Connection Strength
1.342
-
Giant Cell [Granulomatous] Gastritis in Left-sided Paediatric Ulcerative Colitis. J Crohns Colitis. 2019 03 26; 13(3):396-397.
Score: 0.631
-
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
Score: 0.200
-
Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease. J Pediatr Surg. 2016 May; 51(5):786-9.
Score: 0.127
-
Duration of disease may predict response to infliximab in pediatric ulcerative colitis. J Clin Gastroenterol. 2014 Mar; 48(3):248-52.
Score: 0.111
-
Perianal papillomatous Crohn's disease in a male adolescent. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):e9.
Score: 0.106
-
Clinical challenges and images in GI. Aortitis as a rare complication of Crohn's disease. Gastroenterology. 2008 Mar; 134(3):668, 898.
Score: 0.073
-
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017 04 29; 389(10080):1710-1718.
Score: 0.034
-
A Case of an 11-year-old With Cough, Diarrhea, and Findings of Concern in His Lungs and Spleen. Pediatrics. 2016 Mar; 137(3):e20150155.
Score: 0.032
-
Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
Score: 0.027